Amy De La Rosa, PA-C

NPI: 1972730513
Total Payments
$3,146
2024 Payments
$1,860
Companies
24
Transactions
170
Medicare Patients
385
Medicare Billing
$27,850

Payment Breakdown by Category

Food & Beverage$3,124 (99.3%)
Education$22.16 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,124 169 99.3%
Education $22.16 1 0.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $701.09 49 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $403.76 27 $0 (2024)
Janssen Biotech, Inc. $381.36 21 $0 (2024)
QOL Medical, LLC $297.15 11 $0 (2024)
Regeneron Healthcare Solutions, Inc. $194.29 12 $0 (2024)
Enterra Medical, Inc. $172.96 1 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $159.74 8 $0 (2024)
Phathom Pharmaceuticals, Inc. $133.21 8 $0 (2024)
Ardelyx, Inc. $131.16 6 $0 (2024)
Lilly USA, LLC $104.47 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,860 98 ABBVIE INC. ($365.65)
2023 $1,270 71 ABBVIE INC. ($335.44)
2022 $17.15 1 Lundbeck LLC ($17.15)

All Payment Transactions

170 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/17/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $18.16 General
Category: IMMUNOLOGY
12/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $7.51 General
Category: IMMUNOLOGY
12/10/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $15.64 General
Category: Immunology
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.01 General
Category: Gastroenterology
12/03/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $27.87 General
Category: THERAPY FOR CSID
11/22/2024 Medtronic, Inc. VENASEAL (Device) Food and Beverage In-kind items and services $18.87 General
Category: EndoVenous Therapies
11/20/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $15.22 General
Category: INFLAMMATION AND IMMUNOLOGY
11/19/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $20.62 General
Category: GASTROENTEROLOGY
11/13/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $4.73 General
Category: GASTROENTEROLOGY
11/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $19.41 General
Category: IMMUNOLOGY
11/06/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $19.75 General
Category: LIVER DISEASE
10/29/2024 Braintree Laboratories, Inc. SUTAB (Drug), SUFLAVE Food and Beverage In-kind items and services $23.87 General
Category: GI COLON PREP
10/25/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.76 General
Category: IMMUNOLOGY
10/24/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.76 General
Category: GASTROENTEROLOGY
10/23/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $15.69 General
Category: INTERNAL MEDICINE
10/23/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $8.17 General
Category: GASTROENTEROLOGY
10/23/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $4.99 General
Category: ENDOCRINOLOGY
10/23/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $2.60 General
Category: GASTROENTEROLOGY
10/21/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $14.41 General
Category: GASTROENTEROLOGY
10/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.38 General
Category: Immunology
10/17/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $32.35 General
Category: THERAPY FOR CSID
10/16/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $17.31 General
Category: Immunology
10/14/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $18.59 General
Category: INFLAMMATION AND IMMUNOLOGY
10/10/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $6.14 General
Category: GASTROENTEROLOGY
10/09/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $19.65 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 252 269 $59,271 $21,006
2022 3 64 79 $6,818 $3,037
2021 3 69 81 $7,188 $3,806
Total Patients
385
Total Services
429
Medicare Billing
$27,850
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 143 155 $33,635 $12,681 37.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 43 43 $14,276 $4,092 28.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 54 59 $8,732 $3,398 38.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $2,628 $835.74 31.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 36 38 $3,990 $1,968 49.3%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 15 15 $1,268 $641.41 50.6%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 13 26 $1,560 $427.94 27.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 42 43 $4,515 $2,718 60.2%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 16 16 $1,353 $723.68 53.5%
87804 Detection test by immunoassay for influenza virus Office 2021 11 22 $1,320 $364.10 27.6%

About Amy De La Rosa, PA-C

Amy De La Rosa, PA-C is a Physician Assistant healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1972730513.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy De La Rosa, PA-C has received a total of $3,146 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 170 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,124).

As a Medicare-enrolled provider, De La Rosa has provided services to 385 Medicare beneficiaries, totaling 429 services with total Medicare billing of $27,850. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Bedford, TX
  • Active Since 06/22/2009
  • Last Updated 12/06/2022
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1972730513

Products in Payments

  • RINVOQ (Biological) $320.88
  • XIFAXAN (Drug) $275.49
  • STELARA (Biological) $258.00
  • SKYRIZI (Biological) $228.60
  • DUPIXENT (Biological) $194.29
  • SUCRAID (Drug) $151.40
  • Sucraid (Drug) $145.75
  • VOQUEZNA (Drug) $133.21
  • IBSRELA (Drug) $131.16
  • TRULANCE (Drug) $128.27
  • LINZESS (Drug) $105.35
  • OMVOH (Drug) $104.47
  • ENTYVIO (Biological) $102.99
  • REMICADE (Biological) $87.88
  • DIFICID (Drug) $70.36
  • TERLIVAZ (Drug) $46.97
  • IDACIO (Biological) $46.44
  • CREON (Drug) $46.26
  • RESMETIROM (Drug) $42.70
  • EOHILIA (Drug) $36.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Bedford